EDWIN DIAZ: Open Payments
NPI 1821755257 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,956 in 260 payments from 26 companies in 2025. Trend: 2023 $4,828 · 2024 $5,157 · 2025 $5,956
Food & beverage: $5,194Education: $385Travel & lodging: $377
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 64 | $1,190 |
| Inspire Medical Systems, Inc. | 13 | $1,068 |
| AstraZeneca Pharmaceuticals LP | 29 | $680 |
| Stryker Corporation | 36 | $413 |
| Regeneron Healthcare Solutions, Inc. | 13 | $356 |
| JAZZ PHARMACEUTICALS INC. | 10 | $289 |
| Amgen Inc. | 13 | $249 |
| United Therapeutics Corporation | 10 | $224 |
| Verona Pharma, Inc. | 13 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $173 |
Products named: INSPIRE, NUCALA, TRELEGY ELLIPTA, DUPIXENT, TEZSPIRE, XYWAV, FASENRA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
